NSIM
GHDX

North Star Investment Management’s Genomic Health, Inc. GHDX Stock Holding History

North Star Investment Management’s Portfolio GHDX Stock Details GHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-50
Closed -$4K – 1114
2018
Q3 		$4K Buy
+50
New +$2.92K ﹤0.01% 981

Other funds holding GHDX

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

North Star Investment Management's GHDX Position: Q4 2018 in Review

North Star Investment Management sold out of Genomic Health, Inc. (GHDX) in Q4 2018, closing a stake of 50 shares — an estimated $4K sold.

North Star Investment Management first reported a position in GHDX in Q3 2018 and held it in 1 quarter. The position peaked at $4K in Q3 2018. 228 funds tracked by Wall St. Rank hold GHDX as of Q4 2018.

  • North Star Investment Management reported no remaining Genomic Health, Inc. position as of Q4 2018 after selling out during the quarter.
  • North Star Investment Management sold 50 Genomic Health, Inc. shares in Q4 2018, an estimated $4K.
  • North Star Investment Management first reported a position in Genomic Health, Inc. in Q3 2018 and held it in 1 quarter.
  • North Star Investment Management's Genomic Health, Inc. position peaked at $4K in Q3 2018.
  • 228 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2018.

Based on North Star Investment Management's 13F filing for Q4 2018, filed 7 Jan 2019.